Why Schizophrenics Smoke but Have a Lower Incidence of Lung Cancer: Implications for the Treatment of Both Disorders

Journal of Orthomolecular Medicine

Volumn 15, Issue 3, 2000, Pages 141-144

  Hoffer, Abram ^a   Foster, Harold D ^b  

^a University of Victoria ^*  (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009083332     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Diwan A, Castine M, Pomerleau CS, et al: Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders. Schizophr Res, 1998; 33(1-2): 113-8.
2. Lohr JB, Flynn K: Smoking and schizophrenia. Schizophr Res, 1992; 8(2): 93-102.
3. McEnvoy JP, Freudenreich O, Wilson WH: Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiat, 1999; 46(1): 125-9.
4. Masterson E, O'Shea B: Smoking and malignancy in schizophrenia. Brit J Psychiat, 1984; 145: 429-432
5. Foster HD. The geography of schizophrenia: possible links with selenium and calcium deficiencies, inadequate exposure to sunlight and industrialization. J Orthomol Med, 1988; 3(3): 135-140.
6. Brown JS, Foster HD: An update of the selenium deficiency hypothesis. J Orthomol Med, 1996; 11(45): 211-222.
7. Buckman TD, Kling AS, Eiduson S, et al: Glutathione peroxidase and CT Scan abnormalities in schizophrenia. Biol Psychiat, 1987; 22(11): 1349-56.
8. Gulbinat W, Dupoint A, Jablensky A: Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br J Psychiat, Suppl, 1992; (18): 75-83.
9. Snow H: A Treatise: Practical and Theoretic on Cancers and the Cancer Process. London: J & A. Churchill 1893.
10. Innes G, Millar WM: Mortality among psychiatric patients. Scottish Med J, 1970; 15: 142-149.
11. Odegaard O: The excess mortality of the insane. Acta Psychiat Scand, 1952; 27: 353-367.
12. Peller S, Stephenson CS: Cancer in the mentally ill. Public Health Reports, 1941; 56: 132-149.
13. Rice D: No lung cancer in schizophrenics. Brit J Psychiat, 1979; 134: 128.
14. Craig TJ, Lin SP: Cancer and mental illness. Comprehen Psychiat, 1981; 22: 404-410.
15. Hoffer A: Vitamin 83 and Schizophrenia: Discovery, Recovery, Controversy, Kingston (Ontario): Quarry Press. 1998.
16. Hoffer A: Vitamin C & Cancer: Discovery, Recovery, Controversy, Kingston (Ontario): Quarry Press. 2000.
17. Foster HD: Schizophrenia: the latex allergy hypothesis. J Orthomol Med, 1999; 14(2), 83-90.
18. Horrobin DF: Schizophrenia: reconciliation of the dopamine, prostaglandin, and opioid concepts and the role of the pineal. Lancet, 1979; 1: 562-8.
19. Anderson K, Fuxe K, Eneroth P, et al: Mecamylamine induced blockade of nicotine induced inhibition ofgonadotrophin and TSH secretion and of nicotine induced increased catecholamine turnover in the rat hypothalamus. Acta Physiol Scan Suppl, 1980; 479: 27-9.
20. Amano H, Goshima Y, Akema N, et al: Effect of acute nicotine on catecholamine turnover in various rat brain regions. J Pharmacobiodyn, 1989; 12(1): 18-23.
21. Dursun SM, Kutcher S: Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. Med Hypotheses, 1999; 52(2): 101-9.
22. Yamafuji K, Murakami H, Shinozuka M: Anti-tumour activity of dopa, dopamine, noradrenaline or adrenalin and their reaction with nucleic acids. Z Krebsforsch Klin Onkol, 1970; 73(3): 195-203.